Efficacy and Safety of Tofacitinib in Chinese Patients with Rheumatoid Arthritis

BACKGROUND: Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). This study assessed the efficacy and safety of tofacitinib in Chinese patients with RA enrolled in Phase 3 and long-term extension (LTE) studies. METHODS: ORAL Sync was a 1-year, randomized, pla...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhan-Guo, Liu, Yi, Xu, Hu-Ji, Chen, Zhi-Wei, Bao, Chun-De, Gu, Jie-Ruo, Zhao, Dong-Bao, An, Yuan, Hwang, Lie-Ju, Wang, Lisy, Kremer, Joel, Wu, Qi-Zhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247584/
https://www.ncbi.nlm.nih.gov/pubmed/30425195
http://dx.doi.org/10.4103/0366-6999.245157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247584/
https://www.ncbi.nlm.nih.gov/pubmed/30425195
http://dx.doi.org/10.4103/0366-6999.245157

Ejemplares similares